AGP Picks
View all

Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on July 24, 2026

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Maxim Hair Restoration Named Top US Hair Restoration Brand 2026, Reinforcing Its Position Among the Best Hair Restoration Clinics in America
Ireland Bans Electroshock Treatment on Minors: A Major Human Rights Advance, Citizens Commission on Human Rights International Says
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
Sienna Announces Confirmation of Morningstar DBRS Credit Rating
VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LifeMD to Report Second Quarter 2026 Financial Results on August 5
Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD
Affidea beschleunigt Wachstum in Großbritannien durch strategische Partnerschaft mit LIPS Healthcare
Affidea accélère sa croissance au Royaume-Uni en signant un partenariat stratégique avec LIPS Healthcare
HorseFil Official Launch 2026 Effective Men's Energy and Vitality Gummies Highlights Ingredient, Supplement Facts Available in USA
Nordic Naturals Releases Expert Insights on Why Omega-3s Should Be on Back-to-School Checklists
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
AI-Powered Wound Care Market Poised for Revolutionary Disruption as Investment Activity Surges
Allsup Highlights SSDI Barriers And Progress On ADA’s 36th Anniversary
Dr. Ekta Pandya Named Fellow of Pierre Fauchard Academy, Recognized for Leadership in Dentistry and Children's Oral Health
WellSpan Health Awarded $2.8 million to Strengthen Care at Rural Hospitals
Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies
Subcutaneous PD-1 Inhibitors Transition from Novelty to Routine Care as Oncologists Tailor Use by Tumor Type, According to Spherix Global Insights

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Yemen Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.